电子文档交易市场
安卓APP | ios版本
电子文档交易市场
安卓APP | ios版本

医学优质课件精选——《现代脂质三联治疗》

46页
  • 卖家[上传人]:高远
  • 文档编号:115456997
  • 上传时间:2019-11-13
  • 文档格式:PPT
  • 文档大小:2.89MB
  • / 46 举报 版权申诉 马上下载
  • 文本预览
  • 下载提示
  • 常见问题
    • 1、,现代脂质三联治疗,执教教师:XXX,Introduction,Part I,Efficacy - The Power to Reach Target,Key Factor: + Differentiators: LDL Reduction TG HDL LDL/HDL Ratio The Lipid Triad,The LDL/HDL Ratio - Our Strength, Our Story!,A new perception of efficacy,LDL,HDL,Additional risk factor, especially in diabetics,The Lipid Triad - Overview,TG,The Lipid Triad,The Ratio,The Lipid Triad and Strategic Rationale,Part II,No scientific evidence Evidence contradicting this statement A marketing hypothesis to build their LDL story

      2、 Creating the perception of the statin with the strongest efficacy,The lower. .the better?,Its logical,Its measurable,Its practicable,The Lipid Triad - The GPs Perspective,HDL,LDL,Supporting Data from Landmark Studies,Part III,12 10 8 6 4 2 0,% Mortality,Placebo Q1 Q2 Q3 Q4 (low HDL-increase) (high HDL-increase),4S - Study,CAD Mortality per Quartiles of Increases in HDL-Cholesterol,KJEKSHUS J & PEDERSEN T (unpublished),HDL Intervention Trial (VA-HIT),RUBINS HB et al. New Engl J Med 1999; 341:410

      3、,0,6,-31,-4,-35,-30,-25,-20,-15,-10,-5,0,5,10,Cholesterol LDL-C HDL-C Triglycerides,Percent change compared to placebo at 1 year,Secondary Prevention in 2531 men with low HDL-C & LDL-C showed a 22% reduction in combined fatal and non-fatal MI,HDL - Cholesterol as Risk Factor for CHD,LRC - CPPT (Placebo),MRFIT (usual care),Incidence rate of CHD,Incidence rate of CHD,12 10 8 6 4 2 0,100 130 160 190,GORDON DJ et al. Circulation 1989; 79: 8 - 15.,HDL - C mg / dl 65 55 45 35,LDL - Cholesterol mg / dl

      4、,LDL - Cholesterol mg / dl,12 10 8 6 4 2 0,100 130 160 190,0,0.5,1,1.5,2,2.5,3,Framingham Heart Study,CAD risk as a function of LDL-C and HDL-C in men (50 to 70 y),CASTELLI WP. Am J Cardiol 1998; 82:60-65,220 160 100,85,65,45,25,HDL-Cholesterol (mg/dl),LDL Cholesterol (mg/dL),0,2,4,6,8,10,12,14,16,LDL=5,LDL5,HDL=1.08,HDL1.08,LDL/HDL=5,LDL/HDL5,Incidence of cardiac events,(per 1000 person-years),Gemfibrozil,Placebo,LDL-C Tertiles (mmol/L),HDL-C Tertiles (mmol/L),LDL-C/HDL-C Tertiles,Incidence for

      5、 cardiac events vs lipid parameter,Helsinki Heart Study,AFCAPS/TEXCAPS,Apo B/A1 Tertiles,LDL-C/HDL-C Tertiles,1.6,1.4,1.2,1,0.8,0.6,0.4,0.2,0,1.6,1.4,1.2,1,0.8,0.6,0.4,0.2,0,Event Rate per 100 Patient-Years of Risk,Event Rate per 100 Patient-Years of Risk, 0.8889,0.8898- 1.0205,1.0252, 3.7742,3.7744-4.4096,4.4101,LDL/HDL Ratio as Therapeutic Success,Placebo,Statin,24,116,31,245,0,50,100,150,200,250,300,= 5, 5,LDL / HDL - Ratio,Triglycerides 200 mg/dl,Triglycerides = 200 mg/dl,CAD cases per 1,000

      6、 subjects in 6 years,Incidence of CAD vs LDL/HDL ratio by TG level (n = 4559),PROCAM Heart Study,0,50,100,150,200,250,300,3,4,5,5,6,7,LDL/HDL ratio,CHD Incidence/1000 in 6 years,CHD risk according to LDL/HDL ratio at baseline,5,High CHD risk,Medium CHD risk,Low CHD risk,3-5,3,PROCAM Heart Study,Mean values for developing atherosclerotic CHD within 6 years,Variable CHD Development No CHD Development (n = 186) (n = 4221) TC (mg/dl) 251.8 222.9 HDL-C (mg/dl) 39.5 45.2 LDL-C (mg/dl) 176.2 147.1 LDL/

      7、HDL ratio 4.72 3.4 TG (mg/dl) 163.0 134.5,PROCAM Heart Study,Predictive value of risk factors for developing atherosclerotic CHD within 6 years,Variable Risk Ratio Predictive Power % TG 200 mg/dl 2.3 7.5 TC 250 (mg/dl) 2.8 8.3 LDL-C 195 (mg/dl) 3.7 12.0 LDL-C 155 (mg/dl) 3.3 7.1 HDL-C 35 (mg/dl) 3.9 11.0 LDL/HDL ratio 5 6.4 16.5,PROCAM Heart Study,HDL as CHD risk factor showed 186 events, in men aged 40 - 60 years (n = 4407),CHD Incidence per 1, 000 in 6 years,0,20,40,60,80,100,120,140,160, 35 3

      8、5 - 55 55,HDL-C (mg/dL),110,30,21,PROCAM Heart Study,LDL as CHD risk factor showed 177 events in men aged 40 - 60 years, ( n = 4263),CHD Incidence per 1, 000 in 6 years,0,20,40,60,80,100,120,140, 135 135 - 154 155 - 195 195,LDL-C (mg/dL),54,30,16,31,120,PROCAM Heart Study,Expert Opinions,Part IV,The Lipid Triad - Expert Comments,AHA, November 1999 “Evaluating the risk on the bases of LDL alone, is naive” Valentin Fuster, Mount Sinai Medical Center, New York “The LDL/HDL ratio is a much stronger

      9、predictor for the CHD risk than LDL alone” Paul Ridker, Brigham Institute for Womens Hospital, Boston,ACCP, March 2000 “Low HDL is a better indicator of CHD than high LDL as seen in epidemiological studies such as the Framingham Study and recently the VA-HIT Study.” Sander Robins, University Medical Center, Boston “Landmark statin trials have shown consistent benefits on CHD reduction after raising HDL by 5 - 10% irrespective of LDL levels” Christie Ballantyne, Baylor College of Medicine, Houston,The Lipid Triad - Expert Comments,Helsinki Heart Study “The L

      《医学优质课件精选——《现代脂质三联治疗》》由会员高远分享,可在线阅读,更多相关《医学优质课件精选——《现代脂质三联治疗》》请在金锄头文库上搜索。

      点击阅读更多内容
    最新标签
    发车时刻表 长途客运 入党志愿书填写模板精品 庆祝建党101周年多体裁诗歌朗诵素材汇编10篇唯一微庆祝 智能家居系统本科论文 心得感悟 雁楠中学 20230513224122 2022 公安主题党日 部编版四年级第三单元综合性学习课件 机关事务中心2022年全面依法治区工作总结及来年工作安排 入党积极分子自我推荐 世界水日ppt 关于构建更高水平的全民健身公共服务体系的意见 空气单元分析 哈里德课件 2022年乡村振兴驻村工作计划 空气教材分析 五年级下册科学教材分析 退役军人事务局季度工作总结 集装箱房合同 2021年财务报表 2022年继续教育公需课 2022年公需课 2022年日历每月一张 名词性从句在写作中的应用 局域网技术与局域网组建 施工网格 薪资体系 运维实施方案 硫酸安全技术 柔韧训练 既有居住建筑节能改造技术规程 建筑工地疫情防控 大型工程技术风险 磷酸二氢钾 2022年小学三年级语文下册教学总结例文 少儿美术-小花 2022年环保倡议书模板六篇 2022年监理辞职报告精选 2022年畅想未来记叙文精品 企业信息化建设与管理课程实验指导书范本 草房子读后感-第1篇 小数乘整数教学PPT课件人教版五年级数学上册 2022年教师个人工作计划范本-工作计划 国学小名士经典诵读电视大赛观后感诵读经典传承美德 医疗质量管理制度 2 2022年小学体育教师学期工作总结 2022年家长会心得体会集合15篇
    关于金锄头网 - 版权申诉 - 免责声明 - 诚邀英才 - 联系我们
    手机版 | 川公网安备 51140202000112号 | 经营许可证(蜀ICP备13022795号)
    ©2008-2016 by Sichuan Goldhoe Inc. All Rights Reserved.